The Jean Bernard center

What The Jean Bernard center does

The Jean Bernard Center is a private oncology and radiotherapy facility established in 1993 in Le Mans, France, operated under the legal entity GIE VEGA as part of the ILC Group network of cancer centers. The center delivers comprehensive cancer care spanning radiotherapy (including Cyberknife robotic radiosurgery, IMRT, arc therapy, stereotactic and 3D conformal techniques), chemotherapy and immunotherapy administered in day-hospitalization settings, targeted therapies, nuclear medicine imaging (scintigraphy, PET, gamma-camera), and supportive care services such as dietetics, pain management, and photobiomodulation for treatment-related toxicities. Its core technology platform centers on particle accelerators and the Cyberknife system inaugurated in January 2023 through co-investment with Le Mans Métropole, the Department of Sarthe, and the Région Pays de la Loire, making it one of the most advanced radiotherapy platforms in the Pays de la Loire region.

Since January 2023, the center has operated within the Centre de Cancérologie de la Sarthe (CCS), co-located with Clinique Victor Hugo (Elsan Group) and the oncology service of Centre Hospitalier du Mans to provide integrated cancer care continuity. The facility employs approximately 100 staff including 10 specialist physicians in radiotherapy and medical oncology, and serves patient cohorts referred by general practitioners and specialists across the Sarthe region. All practitioners operate under France's Sector 1 convention, meaning no extra billing beyond standard social security tariffs, with revenue collected through the French public healthcare system and supplementary insurance.

The center is connected to a broader ILC Group ecosystem spanning Gentilly, Chartres (COREL), and Laval (Mallet Proux), enabling cross-site technology deployment and clinical research collaboration through Sorecoh. Strategic partnerships with CHU d'Angers for neurological radiosurgery (2024) and Ligue Contre le Cancer for patient support extend its clinical and community footprint. The center also runs pilots in patient-facing digital tools including the Smokecheck mobile screening app, a VenusShare nuclear medicine results portal, and a telephone-based vocal surveillance robot for post-treatment follow-up, reflecting modest digital innovation on top of an established clinical practice.

Name

The Jean Bernard center

Legal name

GIE VEGA

Website

https://cjb.i-l-c.fr

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

251–500 employees

Short description

The Jean Bernard Center is a private French oncology and radiotherapy facility in Le Mans, part of the ILC Group, delivering cancer treatment including Cyberknife radiosurgery, chemotherapy, and nuclear medicine to patients in the Pays de la Loire region under the French public healthcare system.

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

Diagnostic Imaging Centers (621512), Offices of Physicians (62111)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Radiation oncology services
• Cancer treatment center
• Medical oncology care
• Nuclear medicine imaging
• Stereotactic radiotherapy

Headquarters

HQ city

Le Mans

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Services Revenue: The center generates revenue through the provision of cancer treatment services including radiotherapy, chemotherapy, targeted therapies, and nuclear medicine procedures. All practitioners are sector 1 conventioned, meaning no extra billing beyond standard social security rates. Revenue is collected through the French public healthcare system and supplementary health insurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

The Jean Bernard Center is a private oncology and radiotherapy facility that delivers comprehensive cancer care including radiotherapy delivered via particle accelerators (including the Cyberknife), chemotherapy and immunotherapy given in day hospitalization, oral and intravenous targeted therapies, external oncology consultations, supportive care, and nuclear medicine diagnostics such as scintigraphy and PET. It also conducts clinical research through the in-house society Sorecoh and participates in public health education initiatives.

Product overview

The Jean Bernard Center is an oncology center specializing in radiotherapy and cancer treatment, part of the ILC Group. The center offers a comprehensive cancer care portfolio including radiotherapy services (using particle accelerators and Cyberknife), targeted therapies, chemotherapy/immunotherapy, and external consultations. Advanced radiotherapy technologies include IMRT, Arc Therapy, stereotactic radiotherapy, and 3D conformal radiography. The center provides supportive care services (dietetics, wound care, pain management), photobiomodulation for treatment toxicity, and nuclear medicine imaging. Patient-facing services include a results portal (VenusShare), Smokecheck screening application, and vocal robot for post-treatment surveillance. The center operates within the Centre de Cancérologie de la Sarthe alongside Clinique Victor Hugo and Centre Hospitalier du Mans.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy Services Cancer treatment delivered via particle accelerators that emit high-energy X-rays to the precise area of disease, including pre-treatment dosimetric scanning, treatment planning, and daily sessions with weekly medical consultations.
• Targeted Therapies Oral or intravenous drug treatments targeting specific cancer cell anomalies, tumor blood vessels (anti-angiogenic), or the immune system (immunotherapy), following prior genetic testing of the tumor profile.
• Chemotherapy / Immunotherapy (Day Hospitalization) Day-hospitalization cancer treatment administered by perfusion or orally, including chemotherapy, immunotherapy and targeted therapies delivered in cycles within the Centre de Cancérologie de la Sarthe.
• External Oncology Consultations Medical oncology and radiotherapy consultations for cancer diagnosis, treatment planning and ongoing care coordination, provided in Wing A of the Centre de Cancérologie de la Sarthe by appointment upon physician prescription.
• Supportive Care Complementary patient support offering dietitian consultations, wound care nursing, pain management, tobacco cessation, and Photobiomodulation to prevent or treat radiotherapy and chemotherapy toxicities such as mucositis and epithelitis.
• Nuclear Medicine Imaging Scintigraphy and PET imaging using radiotracers injected for diagnostic work, performed on Gamma-Camera or PET scanners. Includes bone, cardiac, pulmonary, thyroid scans and lymphoscintigraphy for sentinel node detection.
• Smokecheck Mobile Application Mobile app for lung health screening using 13 questions to identify symptoms potentially indicating cancer or cardiovascular problems, supporting early detection for smokers and at-risk individuals.

Quantifiable outcome

• 9 patients treated with radiosurgery since 2023
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature9 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Centre Hospitalier Universitaire (CHU) d'AngerscoreStrategic or Co-development Partner · 1 April 2024Medical cooperation agreement for radiosurgery development using Cyberknife technology. Neurosurgery team from CHU d'Angers collaborates with ILC radiotherapy team for treatment of neurological pathologies (tumor, vascular, functional). Multi-disciplinary case review and public-private collaboration benefiting patients.
• Centre de Cancérologie de la Sarthe (CCS)coreStrategic or Co-development Partner · 1 January 2023Comprehensive cancer care center grouping Centre Jean Bernard (ILC), Clinique Victor Hugo (Elsan Group), and Centre Hospitalier du Mans. This integration enables continuity in cancer patient care, combining radiotherapy, chemotherapy, and medical oncology services in one location.
• Clinique Victor Hugo (Elsan Group)coreStrategic or Co-development PartnerCollaboration for comprehensive cancer care within Centre de Cancérologie de la Sarthe. Chemotherapy and hospitalization services (Wing B) are provided at Clinique Victor Hugo. Patient intake and day hospitalization coordination.
• Centre Hospitalier du ManscoreStrategic or Co-development PartnerPartnership within Centre de Cancérologie de la Sarthe for integrated cancer care. Combines expertise with Centre Jean Bernard and Clinique Victor Hugo.
• ILC Group Centers NetworkcoreStrategic or Co-development PartnerThe center belongs to ILC Group which includes Centre Oncologie de Gentilly, Centre COREL (Chartres), and Centre Mallet Proux (Laval). These centers collaborate on innovations including Photobiomodulation (PBM) implementation across all sites in 2026.
• Ligue Contre le CancerminorOthersPatient support association recommended for psychological and financial assistance during and after cancer treatment. Books and resources provided for patient guidance.
• Maison des PatientsminorOthersPatient house attached to Clinique Victor Hugo offering listening and information space for patients and relatives. Hosts AASM association for cancer patient support activities including adapted physical activities.
• SorecohminorStrategic or Co-development PartnerClinical research society in oncology and hematology operating within Centre Jean Bernard. Follows Good Clinical Practice rules and collaborates with clinical trial teams including oncologists, clinical research associates, laboratory technicians, pharmacists, and nurses.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Institut Curie: Paris-based comprehensive cancer center combining hospital care, radiotherapy, and research. Overlaps Centre Jean Bernard in radiotherapy, nuclear medicine, and clinical research services at national scale.
• Institut de Cancérologie de l'Ouest (ICO): Major regional cancer center covering Pays de la Loire and Brittany with full radiotherapy, chemotherapy, and supportive care offerings. Overlaps Centre Jean Bernard's catchment and serves as the most significant regional competitor.
• Centre François Baclesse: Normandy-based Unicancer comprehensive cancer center offering radiotherapy, medical oncology, and nuclear medicine. Comparable specialist hospital model to Centre Jean Bernard with a broader academic mission.
• Centre Léon Bérard: Specialty oncology hospital in Lyon offering comprehensive radiotherapy, chemotherapy, and nuclear medicine. Comparable in service breadth and clinical research capability, though serving a different regional catchment.
• GenesisCare: Global private oncology and radiotherapy operator with European centers offering advanced radiotherapy (including Cyberknife-class technology). Comparable in service-line focus on radiotherapy and patient-throughput model, though at materially larger scale.

Direct peers

• COREL (Centre d'Oncologie et de Radiothérapie d'Eure-et-Loir): ILC Group oncology center in Chartres offering identical radiotherapy and chemotherapy services. Shares group R&D, clinical research, and equipment investment cycles with Centre Jean Bernard.
• Centre d'Oncologie de Gentilly: Sibling center within ILC Group providing radiotherapy, chemotherapy, and oncology consultations. Operates the same group-level protocols and is rolling out Photobiomodulation alongside Centre Jean Bernard, making it the closest operational and governance peer.
• Centre Hospitalier du Mans – Oncology Service: Public hospital oncology service sharing the Centre de Cancérologie de la Sarthe site with Centre Jean Bernard. Provides competing and complementary cancer care in the same regional catchment.
• Clinique Victor Hugo (Elsan Group): Co-located within the Centre de Cancérologie de la Sarthe and delivers chemotherapy/day hospitalization for Centre Jean Bernard patients. Operates a closely linked oncology service line under Elsan Group.
• Centre Mallet Proux: Another ILC Group oncology center (based in Laval) offering the same radiotherapy, chemotherapy, and consultation services under shared group standards. Directly comparable on size, technology stack, and patient mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookweb.facebook.com/pages/clinique-Victor-Hugocentre-JBernard/326923243985030?rf=171605500177049&_rdc=1&_rdr
• LinkedInlinkedin.com/company/centre-jean-bernard

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Jean Bernard center